Autoimmune Disease Series--

Ulcerative Colitis

Ulcerative Colitis

Ulcerative colitis (UC) is a chronic, nonspecific inflammatory intestinal disease primarily affecting the colon and rectum. It is a subtype of inflammatory bowel disease (IBD). Its etiology is closely associated with genetic susceptibility, abnormal immune system activation, intestinal dysbiosis, and environmental factors (e.g., smoking, diet). Patients present with persistent or recurrent symptoms such as diarrhea, mucopurulent bloody stools, abdominal pain, and tenesmus.

Current UC drug development is shifting from broad-spectrum anti-inflammatory agents to targeted therapies. Biologics (e.g., IL-23, TL1A inhibitors) and precision small molecules (e.g., S1PR1-biased agonists) are emerging as frontier directions. Additionally, traditional Chinese medicine (TCM)-based multi-target regulation and novel technologies (nanomedicine, epigenetic interventions) offer new strategies to overcome therapeutic bottlenecks:

► Biologics

  • IL-23/IL-12 Pathway: Xinda Biotech’s Picankibart (IL-23p19 mAb) demonstrates excellent efficacy and safety in Phase II trials, marking China’s first IL-23-targeted UC therapy. Merck’s MK-7240 (TL1A inhibitor) significantly improved endoscopic scores in Phase II trials, achieving a 26.5% clinical remission rate at 12 weeks, and has entered Phase III.
  • Integrin Targets: Vedolizumab, which blocks lymphocyte migration to the gut mucosa, outperforms adalimumab in head-to-head comparisons. Etrolizumab (same target) failed due to inconsistent efficacy.
  • Chemokines/Inflammatory Cytokines: Mendelian randomization studies suggest CXCL5 reduces IBD risk, while CXCL9 increases it, highlighting their therapeutic potential [1]. Genetically predicted lower CD40 levels correlate with reduced IBD risk, likely via immune cell interaction modulation.

► Small Molecule Drugs

  • S1P Receptors: SAR247799 selectively activates S1PR1-G protein signaling, preserving endothelial barrier integrity with fewer off-target effects than non-selective modulators. Pfizer’s Etrasimod and approved Ozanimod show robust efficacy in refractory UC.
  • JAK-STAT Pathway: JAK inhibitors (e.g., tofacitinib) alleviate UC symptoms by blocking inflammatory signaling but face limitations due to cardiovascular and infection risks.
  • Purinergic Signaling: Researchers at China Pharmaceutical University identified P2Y14R inhibition as a novel target, reducing intestinal epithelial necroptosis via the cAMP/PKA/CREB axis.

► TCM Multi-Target Regulation

  • Scutellaria baicalensis-Coptis chinensis Herb Pair: Modulates cytokine signaling, oxidative stress, and apoptosis pathways via AKT1, IL-6, TNF, etc., with core targets including CASP3 and PTGS2 [2].
  • Artemisinin: Targets GALNT2, BMP7, and TGFBR2 to regulate immunity and inflammation, with structure optimization via computer-aided design [3].

► Novel Targets and Technologies

  • Epigenetic Regulation: A Zhejiang University team discovered that enhancer RNA at the Sirpa locus regulates macrophage SIRPα expression, emerging as a UC target. Antisense oligonucleotides validated efficacy in murine models.
  • Protein Interaction Targets: PDIA1 overexpression in UC intestinal epithelia impairs barrier function; its inhibition is under drug screening. Macrophage-specific NOC4L knockout alleviates UC symptoms, showing diagnostic and therapeutic potential.
  • Nanomedicine: Nanoparticle-based drug delivery systems modulate macrophage polarization, reducing pro-inflammatory cytokines (IL-1β, TNF-α).

CUSABIO specializes in providing high-quality research tools, including proteins, antibodies, and ELISA kits. Below is a curated list of popular UC-related targets and reagents for your research needs:

Ulcerative Colitis Drug Targets Related Products

● Target Proteins

CSB-MP004936HU1 Activity Verified

Measured by its binding ability in a functional ELISA. Immobilized CD40 at 2 μg/ml can bind CD40L (CSB-MP004937HU3), the EC50 is 3.112-3.858 ng/ml.

CSB-MP006163HU1 Activity Verified

Measured by its binding ability in a functional ELISA. Immobilized CD152 at 2 μg/ml can bind Anti-CD152 rabbit monoclonal antibody(CSB-RA213310A0HU), the EC50 of human CD152 protein is 27.14-34.82 ng/ml.

CSB-MP011649HU3 Activity Verified

Measured by its binding ability in a functional ELISA. Immobilized Human IL2RA at 2μg/mL can bind Anti-IL2RA recombinant antibody (CSB-RA011649MA1HU),the EC50 is 2.463-3.353 ng/mL.

CSB-MP011661HU2-B Activity Verified

Measured by its binding ability in a functional ELISA. Immobilized Human IL4(CSB-MP011659HU) at 2μg/mL can bind biotinylated Human IL4R,the EC50 is 12.68-14.23 ng/mL

CSB-MP015007HU Activity Verified

Measured by its binding ability in a functional ELISA. Immobilized human CD20 at 2 μg/ml can bind Anti-CD20 recombinant antibody (CSB-RA015007A1HU), the EC50 is 3.243-7.085 ng/mL.

CSB-MP619964HU1 Activity Verified

Measured by its binding ability in a functional ELISA. Immobilized PD-1 at 2 μg/ml can bind Anti-PD-1 recombinant antibody, the EC50 of human PD-1 protein is 6.087-7.854 ng/ml.

CSB-MP023992HU(F2) Activity Verified

Measured by its binding ability in a functional ELISA. Immobilized Human TNFSF15 at 2 μg/ml can bind Anti-TNFSF15 recombinant antibody(CSB-RA023992MA1HU). The EC50 is 0.8389-0.9731 ng/mL

CSB-MP023996HU1 Activity Verified

Measured by its binding ability in a functional ELISA. Immobilized CD30(CSB-MP023983HU1h6) at 5 μg/ml can bind human CD30L, the EC50 is 9.531-12.49 ng/ml.

Target Product Name Source Tag Info Product Code
CCL11 Recombinant Human Eotaxin (CCL11) E.coli N-terminal GST-tagged CSB-EP004775HU
CCL20 Recombinant Human C-C motif chemokine 20 (CCL20), partial E.coli N-terminal GST-tagged CSB-EP004784HU1
CCL20 Recombinant Macaca mulatta Chemokine CCL20/MIP-3ALPHA (CCL20) E.coli N-terminal 10xHis-GST-tagged CSB-EP004784MOW
CCL20 Recombinant Macaca mulatta Chemokine CCL20/MIP-3ALPHA (CCL20) E.coli N-terminal GST-tagged CSB-EP004784MOWe0
CCL20 Recombinant Bovine C-C motif chemokine 20 (CCL20) E.coli N-terminal 6xHis-SUMO-tagged CSB-EP840478BO
CCL20 Recombinant Bovine C-C motif chemokine 20 (CCL20) Yeast N-terminal 6xHis-tagged CSB-YP840478BO
CCL20 Recombinant Human C-C motif chemokine 20 (CCL20), partial E.coli N-terminal 6xHis-GST-tagged CSB-EP004784HU1c0
CCR5 Recombinant Human C-C chemokine receptor type 5 (CCR5) in vitro E.coli expression system N-terminal 10xHis-tagged CSB-CF004844HU
Ccr5 Recombinant Mouse C-C chemokine receptor type 5 (Ccr5), partial Yeast N-terminal 6xHis-tagged CSB-YP004844MO
CD40 Recombinant Human Tumor necrosis factor receptor superfamily member 5 (CD40), partial (Active) Mammalian cell C-terminal Fc-tagged CSB-AP005181HU
CD40 Recombinant Human Tumor necrosis factor receptor superfamily member 5 (CD40), partial (Active) Mammalian cell C-terminal hFc-tagged CSB-MP004936HU1
CD40 Recombinant Pig Tumor necrosis factor receptor superfamily member 5 (CD40), partial E.coli C-terminal 6xHis-tagged CSB-EP851448PI
CD40 Recombinant Pig Tumor necrosis factor receptor superfamily member 5 (CD40), partial Yeast C-terminal hFc-tagged CSB-YP851448PI
CD40 Recombinant Pig Tumor necrosis factor receptor superfamily member 5 (CD40), partial Yeast C-terminal 6xHis-tagged CSB-YP851448PIc7
CD40 Recombinant Human Tumor necrosis factor receptor superfamily member 5 (CD40), partial Baculovirus C-terminal hFc-Avi-tagged CSB-BP004936HU1
CTLA4 Recombinant Human Cytotoxic T-lymphocyte protein 4 (CTLA4), partial E.coli N-terminal 6xHis-tagged CSB-EP006163HU1
Ctla4 Recombinant Mouse Cytotoxic T-lymphocyte protein 4 (Ctla4), partial E.coli N-terminal 10xHis-SUMO-tagged and C-terminal Myc-tagged CSB-EP006163MO1
CTLA4 Recombinant Guinea pig Cytotoxic T-lymphocyte associated protein 4 (CTLA4), partial (Active) Yeast C-terminal 6xHis-tagged CSB-AP005121GU
Ctla4 Recombinant Mouse Cytotoxic T-lymphocyte protein 4 (Ctla4), partial (Active) Mammalian cell C-terminal 6xHis-tagged CSB-AP005301MO
CTLA4 Recombinant Human Cytotoxic T-lymphocyte protein 4 (CTLA4), partial (Active) Mammalian cell C-terminal hFc-tagged CSB-MP006163HU1

● Antibodies

CD40 Recombinant Monoclonal Antibody
CSB-RA004936MA1HU
CSB-RA004936MA1HU IF

Tested Applications:
ELISA, IF, FC

CTLA4 Recombinant Monoclonal Antibody
CSB-RA006163MA1HU
CSB-RA006163MA1HU FC

Tested Applications:
ELISA, WB, IF, FC

MMP9 Recombinant Monoclonal Antibody
CSB-RA014679MA1HU
CSB-RA014679MA1HU IHC

Tested Applications:
ELISA, IHC

PDCD1 Recombinant Monoclonal Antibody
CSB-RA240597A0HU
CSB-RA240597A0HU IHC

Tested Applications:
ELISA, WB, IHC

- Recombinant Antibody

Target Product Name Species Reactivity Tested Applications Code
CD40 CD40 Recombinant Monoclonal Antibody Human ELISA, IF, FC CSB-RA004936MA1HU
CTLA4 CTLA4 Recombinant Monoclonal Antibody Human ELISA, IHC CSB-RA213310A0HU
CTLA4 CTLA4 Recombinant Monoclonal Antibody Human, Mouse ELISA, WB, IF, FC CSB-RA006163MA1HU
CXCL10 CXCL10 Recombinant Monoclonal Antibody Human ELISA, IHC CSB-RA903061A0HU
IL12B IL12B Recombinant Monoclonal Antibody Human ELISA, FC CSB-RA895985A0HU
IL23A IL23A Recombinant Monoclonal Antibody Human ELISA, WB CSB-RA251959A0HU
IL2RA IL2RA Recombinant Monoclonal Antibody Human ELISA, IF CSB-RA011649MA1HU
MADCAM1 MADCAM1 Recombinant Monoclonal Antibody Human ELISA, FC CSB-RA215817A0HU
MMP9 MMP9 Recombinant Monoclonal Antibody Human ELISA, IHC, FC CSB-RA014679A0HU
MS4A1 CD20 Recombinant Monoclonal Antibody Human ELISA CSB-RA015007A0HU
MS4A1 MS4A1 Recombinant Monoclonal Antibody Human ELISA CSB-RA015007A1HU
MS4A1 MS4A1 Recombinant Monoclonal Antibody Human, Dog, Macaca fascicularis ELISA CSB-RA015007MA3HU
MS4A1 MS4A1 Recombinant Monoclonal Antibody Human ELISA, IHC, IF CSB-RA015007MA4HU
PDCD1 PDCD1 Recombinant Monoclonal Antibody Human ELISA, WB, IHC CSB-RA240597A0HU
SELPLG SELPLG Recombinant Monoclonal Antibody Human ELISA, IHC CSB-RA567010A0HU

- Monoclonal Antibody

Target Product Name Species Reactivity Tested Applications Code
CTLA4 CTLA4 Monoclonal Antibody Human ELISA, WB, IHC CSB-MA006163A0m
IL2RA IL2RA Monoclonal Antibody Human ELISA, IHC CSB-MA000266
LAG3 LAG3 Monoclonal Antibody Human ELISA, WB, IHC, FC CSB-MA012719A0m
MS4A1 MS4A1 Monoclonal Antibody Human,Mouse,Rat ELISA, IHC CSB-MA000204
MS4A1 MS4A1 Monoclonal Antibody Human ELISA, IHC CSB-MA996413
TNF TNF Monoclonal Antibody Bovine ELISA CSB-MA084771A0m
TNF TNF Monoclonal Antibody Human,Mouse,Rat ELISA, WB, IHC CSB-MA080271
TNF TNF Monoclonal Antibody Human,Mouse,Rat ELISA, WB, IHC CSB-MA080272

- Polyclonal Antibody

Target Product Name Species Reactivity Tested Applications Code
CCL11 CCL11 Antibody Human ELISA, WB, IHC CSB-PA004775ESR2HU
CCL11 CCL11 Antibody Human, Mouse, Rat ELISA, WB CSB-PA005780
CCL11 CCL11 Antibody Human, Mouse, Rat ELISA, WB CSB-PA004775GA01HU
CCL20 CCL20 Antibody Human, Mouse ELISA, IHC CSB-PA389153
Ccr5 Ccr5 Antibody Mouse ELISA CSB-PA004844LA01MO
CCR5 CCR5 Antibody Human, Mouse ELISA, WB, IF CSB-PA004844LA01HU
CCR5 Phospho-CCR5 (S349) Antibody Human ELISA, WB CSB-PA000640
CCR5 CCR5 Antibody Human ELISA, WB CSB-PA006994
CCR5 Phospho-CCR5 (S336) Antibody Human, Mouse, Rat ELISA, WB CSB-PA006995
CCR5 CCR5 Antibody Human, Mouse, Rat ELISA, IHC CSB-PA006993
CCR5 CCR5 Antibody Human ELISA, WB, IHC CSB-PA792075
CCR5 CCR5 Antibody Human, Mouse, Rat ELISA, WB CSB-PA004844GA01HU
CCR5 CCR5 Antibody Human, Mouse ELISA, IHC CSB-PA548882
CCR5 CCR5 Antibody Human, Mouse ELISA, IHC CSB-PA265884
CCR5 CCR5 Antibody Human ELISA, WB CSB-PA572290
CCR5 Phospho-CCR5 (Ser349) Antibody Human ELISA, WB CSB-PA942331
CD3D CD3D Antibody Human ELISA, IHC CSB-PA004930ESR1HU
CD3D CD3D Antibody Human ELISA, WB CSB-PA001452
CD3D CD3D Antibody Human ELISA, WB CSB-PA005826
CD3D CD3D Antibody Human, Mouse, Rat ELISA, WB, IF CSB-PA004930GA01HU

● ELISA Kits

Target Product Name Sample Types Detection Range Code
CCL11 Human eosinophil chemotactic factor,ECF ELISA Kit serum, plasma, cell culture supernates, tissue homogenates 31.25 pg/mL-2000 pg/mL CSB-E04533h
CCL11 Rat Eotaxin 1 (Eotaxin 1/CCL11/ECF)ELISA Kit serum, plasma, tissue homogenates 15.6 pg/ml -1000 pg/ml CSB-E07319r
CCL20 Human Macrophage Inflammatory Protein-3α,MIP-3α ELISA kit serum, plasma, cell culture supernates 15.6 pg/mL-1000 pg/mL CSB-E04667h
CCL20 Mouse Macrophage Inflammatory Protein 3α,MIP-3α ELISA kit serum, plasma, tissue homogenates 39 pg/ml - 2500 pg/ml CSB-E04668m
CCL20 Rat macrophage inflammatory protein 3α,MIP-3α ELISA Kit serum, plasma, tissue homogenates 0.156 ng/ml - 10 ng/ml CSB-E04669r
CD40 Mouse Tumor necrosis factor receptor superfamily member 5(CD40) ELISA kit Request Information CSB-EL004936MO
CD6 Mouse cluster of differentiation 6(CD6) ELISA Kit Request Information CSB-EL004949MO
CTLA4 Human cytotoxic T lymphocyte associated antigen 4,CTLA-4 ELISA Kit serum, plasma, tissue homogenates 125 pg/mL-8000 pg/mL CSB-E09171h
CTLA4 Mouse cytotoxic T lymphocyte associated antigen 4,CTLA-4 ELISA Kit serum, plasma, tissue homogenates 0.312 ng/mL-20 ng/mL CSB-E13637m
CXCL10 Human interferon-inducible protein 10,IP-10 ELISA Kit serum, plasma, tissue homogenates 31.25 pg/mL-2000 pg/mL CSB-E08181h
CXCL10 Rat interferon-inducible protein 10,IP-10 ELISA Kit serum, plasma, tissue homogenates 781.25 pg/mL-50000 pg/mL CSB-E08182r
CXCL10 Mouse interferon-inducible protein 10,IP-10 ELISA Kit serum, plasma, tissue homogenates 0.312 ng/ml - 20 ng/ml CSB-E08183m
CXCL10 Monkey C-X-C motif chemokine 10(CXCL10) ELISA kit serum, plasma, tissue homogenates 62.5 pg/mL-4000 pg/mL CSB-EL006240RH
IL12A Bovine Interleukin 12,IL-12 ELISA Kit serum, plasma, tissue homogenates 6.25 pg/mL-400 pg/mL CSB-E14010B
IL12B Human Interleukin 12,IL-12/P40 ELISA KIT serum, plasma, tissue homogenates 0.156 ng/ml-10 ng/ml CSB-E04598h
IL12B Mouse interleukin 12,IL-12/P40 ELISA KIT serum, plasma, tissue homogenates 15.6 pg/mL-1000 pg/mL CSB-E07360m
IL12B Pig Interleukin 12,IL-12/P40 ELISA KIT serum, plasma, cell culture supernates 15.6 pg/mL-1000 pg/mL CSB-E11341p
IL12B Goat interleukin 12,IL-12/P40 ELISA KIT serum, plasma, tissue homogenates, cell lysates 9.38 pg/mL-600 pg/mL CSB-E12103G
IL13 Human Interleukin 13,IL-13 ELISA KIT serum, plasma, tissue homogenates 0.39 ng/ml-25 ng/ml. CSB-E04601h
IL13 Mouse Interleukin 13,IL-13 ELISA Kit serum, plasma, tissue homogenates 78 pg/ml - 5000 pg/ml CSB-E04602m


References

[1] Identifying Novel Inflammatory Protein Biomarkers and Drug Targets of Inflammatory Bowel Disease by Integrating Mendelian Randomization, Bioinformatics, and Druggability Analysis. Int Arch Allergy Immunol, 2025.

[2] Molecular Targets and Mechanisms of Scutellariae radix - Coptidis rhizoma Drug Pair for the Treatment of Ulcerative Colitis Based on Network Pharmacology and Molecular Docking. Evid Based Complement Alternat Med, 2021.

[3] A Pharmacoinformatics Analysis of Artemisinin Targets and de novo Design of Hits for Treating Ulcerative Colitis. Front Pharmacol, 2022.

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2025 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1